OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orexin receptor antagonists as therapeutic agents for insomnia
Ana Clementina Equihua-Benítez, Alberto K. De la Herrán-Arita, René Drucker-Colı́n
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 57
Ana Clementina Equihua-Benítez, Alberto K. De la Herrán-Arita, René Drucker-Colı́n
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 57
Showing 26-50 of 57 citing articles:
Daridorexant for the treatment of insomnia disorder: findings and implications
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 11, pp. 1749-1761
Closed Access | Times Cited: 12
Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant
Habibolah Khazaie, Masoud Sadeghi, Sepideh Khazaie, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Habibolah Khazaie, Masoud Sadeghi, Sepideh Khazaie, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 11
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Melatonin, Ramelteon, Suvorexant, and Dexmedetomidine to Promote Sleep and Prevent Delirium in Critically Ill Patients
G Fontaine, Caroline Der‐Nigoghossian, Leslie A. Hamilton
Critical Care Nursing Quarterly (2020) Vol. 43, Iss. 2, pp. 232-250
Closed Access | Times Cited: 14
G Fontaine, Caroline Der‐Nigoghossian, Leslie A. Hamilton
Critical Care Nursing Quarterly (2020) Vol. 43, Iss. 2, pp. 232-250
Closed Access | Times Cited: 14
The Evolution and Function of Sleep
Yu Hayashi, Chih-Yao Liu
Diversity and commonality in animals (2017), pp. 343-366
Closed Access | Times Cited: 14
Yu Hayashi, Chih-Yao Liu
Diversity and commonality in animals (2017), pp. 343-366
Closed Access | Times Cited: 14
Comparative efficacy and acceptability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis
Franco De Crescenzo, Francesca Foti, Marco Ciabattini, et al.
Cochrane library (2016)
Open Access | Times Cited: 12
Franco De Crescenzo, Francesca Foti, Marco Ciabattini, et al.
Cochrane library (2016)
Open Access | Times Cited: 12
Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder
Kristin Waters
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Kristin Waters
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Mechanism of action of suvorexant
Stephen M. Stahl
CNS Spectrums (2016) Vol. 21, Iss. 3, pp. 215-218
Open Access | Times Cited: 11
Stephen M. Stahl
CNS Spectrums (2016) Vol. 21, Iss. 3, pp. 215-218
Open Access | Times Cited: 11
Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials
Sebastian Heidenreich, Melissa Ross, Gin Nie Chua, et al.
SLEEP (2022) Vol. 45, Iss. 11
Open Access | Times Cited: 6
Sebastian Heidenreich, Melissa Ross, Gin Nie Chua, et al.
SLEEP (2022) Vol. 45, Iss. 11
Open Access | Times Cited: 6
Discovery of Small-Molecule Antagonists of Orexin 1/2 Receptors from Traditional Chinese Medicinal Plants with a Hypnotic Effect
Jia He, Jing Fang, Yuxin Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 542-542
Open Access | Times Cited: 3
Jia He, Jing Fang, Yuxin Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 542-542
Open Access | Times Cited: 3
Orexin receptors: Targets and applications
Subhiksha Subramanian, Mirunalini Ravichandran
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 1, pp. 72-80
Closed Access | Times Cited: 7
Subhiksha Subramanian, Mirunalini Ravichandran
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 1, pp. 72-80
Closed Access | Times Cited: 7
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
Eva Mezeiová, Jana Janočková, Jan Konečný, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104179-104179
Closed Access | Times Cited: 6
Eva Mezeiová, Jana Janočková, Jan Konečný, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104179-104179
Closed Access | Times Cited: 6
Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study
Yuichi Inoue, Takeshi Watanabe, Shuya Takashima, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 5, pp. 1067-1074
Open Access | Times Cited: 6
Yuichi Inoue, Takeshi Watanabe, Shuya Takashima, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 5, pp. 1067-1074
Open Access | Times Cited: 6
Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review
Ume Habiba, Radeyah Waseem, Taha Gul Shaikh, et al.
Neurological Sciences (2023) Vol. 44, Iss. 5, pp. 1533-1541
Closed Access | Times Cited: 2
Ume Habiba, Radeyah Waseem, Taha Gul Shaikh, et al.
Neurological Sciences (2023) Vol. 44, Iss. 5, pp. 1533-1541
Closed Access | Times Cited: 2
Opportunities and perspectives for developing orexin receptor antagonists
Michel A. Steiner, Christopher J. Winrow
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 4
Michel A. Steiner, Christopher J. Winrow
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 4
The Orexinergic System: Neurobiology and Clinical Implications
Shorouq Motwani, Avinash De Sousa
Annals of Indian Psychiatry (2024) Vol. 8, Iss. 2, pp. 89-92
Open Access
Shorouq Motwani, Avinash De Sousa
Annals of Indian Psychiatry (2024) Vol. 8, Iss. 2, pp. 89-92
Open Access
The Effectiveness of Suvorexant Compared to a Placebo in the Treatment of Insomnia and Sleep Disorders: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Ahmed Abdulaziz Alqerafi, Yasseer Youssef Sonbul, Fahad Mohammed Alahwal, et al.
(2024) Vol. 1, Iss. 3, pp. 1103-1110
Closed Access
Ahmed Abdulaziz Alqerafi, Yasseer Youssef Sonbul, Fahad Mohammed Alahwal, et al.
(2024) Vol. 1, Iss. 3, pp. 1103-1110
Closed Access
Orexin receptors: a journey through their discovery to the development of suvorexant, the new sleeping pill
Nishanthi Anandabaskar, Mourouguessine Vimal, Sandhiya Selvarajan, et al.
International Journal of Basic & Clinical Pharmacology (2016), pp. 573-578
Open Access | Times Cited: 2
Nishanthi Anandabaskar, Mourouguessine Vimal, Sandhiya Selvarajan, et al.
International Journal of Basic & Clinical Pharmacology (2016), pp. 573-578
Open Access | Times Cited: 2
Orexin/Hypocretin Antagonists in Insomnia: From Bench to Clinic
Alberto K. De la Herrán-Arita, Ana Clementina Equihua-Benítez, René Drucker-Colı́n
Milestones in drug therapy (2014), pp. 191-207
Closed Access | Times Cited: 2
Alberto K. De la Herrán-Arita, Ana Clementina Equihua-Benítez, René Drucker-Colı́n
Milestones in drug therapy (2014), pp. 191-207
Closed Access | Times Cited: 2
Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of orexin receptor
Fatemeh Piri, Mahmoud Elahdadi Salmani, Hamid Sepehri
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 1, pp. 166-171
Open Access | Times Cited: 1
Fatemeh Piri, Mahmoud Elahdadi Salmani, Hamid Sepehri
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 1, pp. 166-171
Open Access | Times Cited: 1
Brain Orexin Receptors and Nicotine
Rita Machaalani, Nicholas J. Hunt, Karen A. Waters
Elsevier eBooks (2016), pp. 133-145
Closed Access | Times Cited: 1
Rita Machaalani, Nicholas J. Hunt, Karen A. Waters
Elsevier eBooks (2016), pp. 133-145
Closed Access | Times Cited: 1
Wake-Promoting Agents; Insights into Clinical Use and Molecular Perspectives
Bijan Zare, Behrooz Moosavi, Mohammad Nami
Journal of Advanced Medical Sciences and Applied Technologies (2016) Vol. 2, Iss. 1, pp. 129-129
Closed Access | Times Cited: 1
Bijan Zare, Behrooz Moosavi, Mohammad Nami
Journal of Advanced Medical Sciences and Applied Technologies (2016) Vol. 2, Iss. 1, pp. 129-129
Closed Access | Times Cited: 1
Und soodustavate ravimite kliiniline farmakoloogia ja kasutamise suundumused Eestis
Katrin Sonn, Ott Laius, Alar Irs
Eesti Arst (2015)
Closed Access | Times Cited: 1
Katrin Sonn, Ott Laius, Alar Irs
Eesti Arst (2015)
Closed Access | Times Cited: 1
Development of New Therapeutical Agents for Treatment of Insomnia and Other Sleeps Disorders
Gloria Martín, Antonio Guglietta
Milestones in drug therapy (2014), pp. 85-107
Closed Access | Times Cited: 1
Gloria Martín, Antonio Guglietta
Milestones in drug therapy (2014), pp. 85-107
Closed Access | Times Cited: 1
